Abstract: This invention relates to the synthesis of a bicyclic ketoester compound of the formula 1 obtained by cyclizing a diazo compound of formula 2: in the presence of a rhodium catalyst. ##STR1## By adding an effective amount of a Lewis acid to the cyclization reaction, the reaction selectively produces the 1-beta methyl isomer, and epimerization of the 1-beta methyl compound to the 1-alpha isomer is minimized.
Type:
Grant
Filed:
January 25, 1994
Date of Patent:
February 20, 1996
Assignee:
Merck & Co., Inc.
Inventors:
Thomas Meng-Han Liu, Joseph E. Lynch, Ralph P. Volante
Abstract: A compound having the formula ##STR1## which is an anti-fungal agent is described. The producing organism Colletotricum accutatum is also described, along with a method of production.
Type:
Grant
Filed:
October 21, 1994
Date of Patent:
October 24, 1995
Assignee:
Merck & Co., Inc.
Inventors:
Evon A. Bolessa, Robert E. Schwartz, Gerald F. Bills, Robert A. Giacobbe, Fernando Pelaez Perez, Angeles Cabello Arroyo, Teresa Diez Matas, Isabel Martin Fernandez, Francisca Vincente Perez, Suzanne M. Mandala, Deborah L. Zink, Rosemary Thornton, John R. Thompson, James E. Curotto
Abstract: A compound of the formula I is disclosed. ##STR1## R.sup.13 represents hydrogen, NH.sub.2, C1-4 alkyl, C1-4 alkylamino or di(C1-4) alkylamino-;Y represents CH or N;Y" represents (a) CR.sup.y' R.sup.z' with R.sup.y' and R.sup.z' hydrogen, C1-6 alkyl, C.sub.3-8 cycloalkyl or C.sub.1-6 alkyl substituted with C.sub.3-8 cycloalkyl, or (b) N substituted with OR.sup.14 with R.sup.14 representing H, C.sub.1-4 alkyl or C.sub.1-4 alkyl substituted with COOH.Ar represents: ##STR2## One of R.sup.1 and R.sup.2 independently represent H, W as defined below or one of the groups (a) through (d) below, and the other represents H or W. Pharmaceutical compositions and methods of use are also included.
Abstract: A carbapenem antibiotic of the formula I ##STR1## is disclosed. The variable X.sup..crclbar. represents a counterion. Pharmaceutical compositions and methods of use are also disclosed.
Type:
Grant
Filed:
February 15, 1994
Date of Patent:
September 19, 1995
Assignee:
Merck & Co., Inc.
Inventors:
Mark L. Greenlee, Frank P. DiNinno, Milton L. Hammond
Abstract: A process of synthesizing a compound of the formula 1: ##STR1## is disclosed, which comprises reacting a compound of the formula 2: ##STR2## with diphenylphosphine in the presence of an amine base and a nickel catalyst to produce a compound of formula 1.
Type:
Grant
Filed:
June 1, 1994
Date of Patent:
March 21, 1995
Assignee:
Merck & Co., Inc.
Inventors:
Dongwei Cai, Joseph F. Payack, Thomas R. Verhoeven
Abstract: Carbapenems of the formula ##STR1## are useful antibacterial agents. Compositions containing such compounds and methods of use are also disclosed.
Abstract: Disclosed are carbapenems of the formula ##STR1## which are 2-(9-fluorenonyl)-carbapenems useful as antibacterial agents. Intermediates for preparation of these compounds is also disclosed.
Type:
Grant
Filed:
October 26, 1992
Date of Patent:
October 18, 1994
Assignee:
Merck & Co., Inc.
Inventors:
Mark L. Greenlee, Frank P. DiNinno, Lovji D. Cama, James V. Heck
Abstract: Triazolyl and tetrazolyl phenyl substituted carbapenems of the formula I are disclosed. ##STR1## One or two of the variables X, Y and Z represent nitrogen atoms. The heteroaryl ting may be charged or uncharged.Pharmaceutical compositions and methods of treatment are also disclosed.
Abstract: The present invention is directed to intermediates of the following formula which are useful in the preparation of Carbapenem-antibiotics ##STR1##
Type:
Grant
Filed:
November 19, 1992
Date of Patent:
August 16, 1994
Assignee:
Merck & Co., Inc.
Inventors:
Ann DeCamp, Ulf H. Dolling, Yulan Li, Dale L. Rieger, Nobuyoshi Yasuda, Lyndon C. Xavier